Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omsleep is a medical technology company focused on developing innovative, user-friendly solutions for obstructive sleep apnea (OSA). The company's primary product is a disposable, single-use oral appliance designed to stabilize the tongue and maintain an open airway during sleep. Unlike traditional CPAP machines or custom-fitted oral appliances, Omsleep's device is intended to be a low-cost, accessible alternative that improves patient compliance and sleep quality. The company was founded by experts in sleep medicine, including Dr. David P. White, to address the significant unmet need in the OSA treatment market. The device is FDA-cleared and represents a shift toward more convenient, non-invasive sleep therapy options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OMSLEEP.